US4511001012

We assign a fundamental rating of **3** out of 10 to **IEP**. **IEP** was compared to 9 industry peers in the **Industrial Conglomerates** industry. While **IEP** seems to be doing ok healthwise, there are quite some concerns on its profitability. **IEP** has a valuation in line with the averages, but it does not seem to be growing. **IEP** also has an excellent dividend rating.

In the past year **IEP** has reported negative net income.

In the past 5 years **IEP** always reported negative net income.

In multiple years **IEP** reported negative operating cash flow during the last 5 years.

The **Return On Assets** of **IEP** (**-2.80%**) is comparable to the rest of the industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -2.8% | ||

ROE | -18.48% | ||

ROIC | N/A |

ROA(3y)-2.01%

ROA(5y)-3.38%

ROE(3y)-14.17%

ROE(5y)-22.03%

ROIC(3y)N/A

ROIC(5y)N/A

The **Gross Margin** of **IEP** (**8.63%**) is worse than **88.89%** of its industry peers.

In the last couple of years the **Gross Margin** of **IEP** has declined.

Industry Rank | Sector Rank | ||
---|---|---|---|

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 8.63% |

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5Y-16.02%

The number of shares outstanding for **IEP** has been increased compared to 1 year ago.

Compared to 5 years ago, **IEP** has more shares outstanding

The debt/assets ratio for **IEP** is higher compared to a year ago.

Looking at the **Debt to FCF ratio**, with a value of **3.16**, **IEP** is in the better half of the industry, outperforming **77.78%** of the companies in the same industry.

Looking at the **Debt to Equity ratio**, with a value of **2.43**, **IEP** is in line with its industry, outperforming **55.56%** of the companies in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.43 | ||

Debt/FCF | 3.16 | ||

Altman-Z | N/A |

ROIC/WACCN/A

WACC6.7%

Industry Rank | Sector Rank | ||
---|---|---|---|

Current Ratio | 3.14 | ||

Quick Ratio | 2.76 |

The **Earnings Per Share** has grown by an impressive **35.75%** over the past year.

Measured over the past years, **IEP** shows a decrease in **Revenue**. The Revenue has been decreasing by **-2.31%** on average per year.

EPS 1Y (TTM)35.75%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%0%

Revenue 1Y (TTM)-12.69%

Revenue growth 3Y19.62%

Revenue growth 5Y-2.31%

Sales Q2Q%-12%

Based on estimates for the next years, **IEP** will show a very strong growth in **Earnings Per Share**. The EPS will grow by **64.29%** on average per year.

EPS Next Y63.74%

EPS Next 2Y64.29%

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next Year-14.8%

Revenue Next 2Y-8.47%

Revenue Next 3YN/A

Revenue Next 5YN/A

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

A **Price/Forward Earnings** ratio of **18.08** indicates a rather expensive valuation of **IEP**.

88.89% of the companies in the same industry are more expensive than **IEP**, based on the **Price/Forward Earnings** ratio.

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 18.08 |

Compared to the rest of the industry, the **Price/Free Cash Flow** ratio of **IEP** indicates a rather cheap valuation: **IEP** is cheaper than 88.89% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

P/FCF | 3.36 | ||

EV/EBITDA | N/A |

The low **PEG Ratio(NY)**, which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y64.29%

EPS Next 3YN/A

With a **Yearly Dividend Yield** of **28.53%**, **IEP** is a good candidate for dividend investing.

Compared to an average industry **Dividend Yield** of **7.03**, **IEP** pays a better dividend. On top of this **IEP** pays more dividend than 100.00% of the companies listed in the same industry.

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 28.53% |

The dividend of **IEP** is nicely growing with an annual growth rate of **8.09%**!

Dividend Growth(5Y)8.09%

Div Incr Years0

Div Non Decr Years0

The earnings of **IEP** are negative and hence is the payout ratio. **IEP** will probably not be able to sustain this dividend level.

The dividend of **IEP** is growing, but earnings are growing more, so the dividend growth is sustainable.

DP-71.23%

EPS Next 2Y64.29%

EPS Next 3YN/A

**ICAHN ENTERPRISES LP**

NASDAQ:IEP (10/14/2024, 8:00:02 PM)

After market: 14.87 +0.07 (+0.51%)**14.795**

**+0.53 (+3.68%) **

Chartmill FA Rating

GICS SectorIndustrials

GICS IndustryGroupCapital Goods

GICS IndustryIndustrial Conglomerates

Earnings (Last)

Earnings (Next)

Inst Owners

Inst Owner Change

Ins Owners

Ins Owner Change

Market Cap7.03B

Analysts

Price Target

Dividend

Industry Rank | Sector Rank | ||
---|---|---|---|

Dividend Yield | 28.53% |

Dividend Growth(5Y)

DP

Div Incr Years

Div Non Decr Years

Ex-Date

Surprises & Revisions

EPS beat(2)

Avg EPS beat(2)

Min EPS beat(2)

Max EPS beat(2)

EPS beat(4)

Avg EPS beat(4)

Min EPS beat(4)

Max EPS beat(4)

EPS beat(8)

Avg EPS beat(8)

EPS beat(12)

Avg EPS beat(12)

EPS beat(16)

Avg EPS beat(16)

Revenue beat(2)

Avg Revenue beat(2)

Min Revenue beat(2)

Max Revenue beat(2)

Revenue beat(4)

Avg Revenue beat(4)

Min Revenue beat(4)

Max Revenue beat(4)

Revenue beat(8)

Avg Revenue beat(8)

Revenue beat(12)

Avg Revenue beat(12)

Revenue beat(16)

Avg Revenue beat(16)

PT rev (1m)

PT rev (3m)

EPS NQ rev (1m)

EPS NQ rev (3m)

EPS NY rev (1m)

EPS NY rev (3m)

Revenue NQ rev (1m)

Revenue NQ rev (3m)

Revenue NY rev (1m)

Revenue NY rev (3m)

Valuation

Industry Rank | Sector Rank | ||
---|---|---|---|

PE | N/A | ||

Fwd PE | 18.08 | ||

P/S | |||

P/FCF | |||

P/OCF | |||

P/B | |||

P/tB | |||

EV/EBITDA |

EPS(TTM)

EY

EPS(NY)

Fwd EY

FCF(TTM)

FCFY

OCF(TTM)

OCFY

SpS

BVpS

TBVpS

PEG (NY)N/A

PEG (5Y)N/A

Profitability

Industry Rank | Sector Rank | ||
---|---|---|---|

ROA | -2.8% | ||

ROE | -18.48% | ||

ROCE | |||

ROIC | |||

ROICexc | |||

ROICexgc | |||

OM | N/A | ||

PM (TTM) | N/A | ||

GM | 8.63% | ||

FCFM |

ROA(3y)

ROA(5y)

ROE(3y)

ROE(5y)

ROIC(3y)

ROIC(5y)

ROICexc(3y)

ROICexc(5y)

ROICexgc(3y)

ROICexgc(5y)

ROCE(3y)

ROCE(5y)

ROICexcg growth 3Y

ROICexcg growth 5Y

ROICexc growth 3Y

ROICexc growth 5Y

OM growth 3Y

OM growth 5Y

PM growth 3Y

PM growth 5Y

GM growth 3Y

GM growth 5Y

F-Score

Asset Turnover0.54

Health

Industry Rank | Sector Rank | ||
---|---|---|---|

Debt/Equity | 2.43 | ||

Debt/FCF | |||

Debt/EBITDA | |||

Cap/Depr | |||

Cap/Sales | |||

Interest Coverage | |||

Cash Conversion | |||

Profit Quality | |||

Current Ratio | 3.14 | ||

Quick Ratio | 2.76 | ||

Altman-Z |

F-Score

WACC

ROIC/WACC

Cap/Depr(3y)

Cap/Depr(5y)

Cap/Sales(3y)

Cap/Sales(5y)

Profit Quality(3y)

Profit Quality(5y)

High Growth Momentum

Growth

EPS 1Y (TTM)35.75%

EPS 3YN/A

EPS 5Y

EPS Q2Q%

EPS Next Y63.74%

EPS Next 2Y

EPS Next 3Y

EPS Next 5Y

Revenue 1Y (TTM)-12.69%

Revenue growth 3Y19.62%

Revenue growth 5Y

Sales Q2Q%

Revenue Next Year

Revenue Next 2Y

Revenue Next 3Y

Revenue Next 5Y

EBIT growth 1Y

EBIT growth 3Y

EBIT growth 5Y

EBIT Next Year

EBIT Next 3Y

EBIT Next 5Y

FCF growth 1Y

FCF growth 3Y

FCF growth 5Y

OCF growth 1Y

OCF growth 3Y

OCF growth 5Y